The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Histone acetylation and transcriptional regulatory mechanisms
Open accessAbstract
More than 30 years ago, Vincent Allfrey proposed that histone acetylation was associated with transcriptional activity in eukaryotic cells (Allfrey et al. 1964; Pogo et al. 1966). Subsequently, acetylated core histones were shown to preferentially associate with transcriptionally active chromatin (Sealy and Chalkley 1978; Vidali et al. 1978; Hebbes et al. 1988). Acetylation occurs at lysine residues on the amino-terminal tails of the histones, thereby neutralizing the positive charge of the histone tails and decreasing their affinity for DNA (Hong et al. 1993). As a consequence, histone acetylation alters nucleosomal conformation (Norton et al. 1989), which can increase the accessibility of transcriptional regulatory proteins to chromatin templates (Lee et al. 1993; Vettese-Dadey et al. 1996). Taken together, these observations suggested how histone acetylation could result in increased transcriptional activity in vivo. However, there was essentially no information about the cause and effect relationship between histone acetylation and transcriptional activity or about the underlying molecular mechanisms. A mechanistic and physiologically relevant connection between histone acetylation and transcriptional regulation was initially provided by two independent lines of evidence. First, yeast cells unable to acetylate the histone H4 tail because of mutations of the target lysine residues show altered patterns of transcription (Durrin et al. 1991). However, these mutations broadly affect chromatin structure in vivo, and hence are likely to influence other molecular processes involving DNA (e.g., DNA replication and repair, recombination, chromosome segregation). Second, treatment of mammalian cells with potent inhibitors of histone deacetylase activity such as trapoxin or trichostatin A resulted in increased expression of a variety of genes (Yoshida et al. 1995). However, these drugs might inhibit other cellular targets, and they affect a variety of cellular processes, including cell proliferation, apoptosis, differentiation, and DNA synthesis. Although these observations were suggestive, understanding of the relationship between chromatin structure and transcription regulation was hampered significantly by a lack of knowledge about the enzymes that acetylate and deacetylate histones. In the past 2 years, our understanding of the causal relationship between histone acetylation and gene expression has been enhanced dramatically by the identification of proteins with intrinsic histone acetylase and deacetylase activity (Brownell et al. 1996; for recent reviews, see Grunstein 1997; Pazin and Kadonaga 1997; Wade et al. 1997). Of particular significance, some of these enzymes had been identified previously as components of the RNA polymerase II (Pol II) transcription machinery itself, proteins that associate with transcriptional regulatory factors, or proteins that positively or negatively affect transcription in vivo. These discoveries have led to a major paradigm shift. It is now clear that chromatin structure and modification can not be viewed as a process that is independent of transcriptional initiation, that is, chromatin is not simply a structure that serves to compact DNA in the nucleus and provide a relatively passive substrate for the action of transcription factors. Instead, histone acetylases and deacetylases provide a critical link between chromatin structure and transcriptional output, and this link is now accessible to experimental intervention. This review will focus on molecular mechanisms by which histone acetylation affects transcriptional activity in living cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Histone deacetylation promotes the condensation of chromatin which, in turn, promotes transcriptional repression (Struhl, 1998).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Struhl, 1998
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As for histone modification, it impacts chromatin structure and DNA packaging (37) [e.g., the acetylation of histones may render DNA more or less accessible to transcription factors, leading to enhanced or reduced transcriptional activity (53)].”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R. D., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,788
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,828
Brownell, J. E., Zhou, J., Ranalli, T. A., Kobayashi, R., Edmondson, D. G., Dent, S., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,636
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X., Ogryzko, V. V., Nishikawa, J., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,497
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,480
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G. W., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Oñate, S. A., Tsai, S. Y., Tsai, M., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,242
Flagged first, then by citations
2 of the 61 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Rundlett, S.E., A.A. Carmen, R. Kobayashi, S. Bavykin, B.M. Turner, and M. Grunstein. 1996. HDA1 and RPD3 are mem- bers of distinct yeast histone deacetylase complexes. Proc. Natl. Acad. Sci. 93: 14503-14508.
Cited by
Sorted by citations
Items 401–500 of 1,002
Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity
Schwartz, C., Schachtrup, K., Mink, S., Schmolke, M., Budde, B., Wenning, D., & Klempnauer, K.-H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg076 · Cited by 122
Distribution of acetylated histones resulting from Gal4‐VP16 recruitment of SAGA and NuA4 complexes
Vignali, M., Steger, D. J., Neely, K. E., & Workman, J. L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2629 · Cited by 127
Chromatin remodeling, metabolism and circadian clocks: The interplay of CLOCK and SIRT1
Grimaldi, B., Nakahata, Y., Kaluzová, M., Masubuchi, S., & Sassone‐Corsi, P. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.035 · Cited by 121
Sasaki, S., Lesoon‐Wood, L. A., Dey, A., Kuwata, T., Weintraub, B. D., Humphrey, G. W., Yang, W., Seto, E., Yen, P. M., Howard, B. H., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5389 · Cited by 120
Acetylation of GATA‐3 affects T‐cell survival and homing to secondary lymphoid organs
Yamagata, T., Mitani, K., Oda, H., Suzuki, T., Honda, H., Asai, T., Maki, K., Nakamoto, T., & Hirai, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4676 · Cited by 121
Histone Deacetylase in Carcinogenesis and Its Inhibitors as Anti-cancer Agents
Kim, D. H., Kim, M., & Kwon, H.-J. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.110 · Cited by 123
Regulation of E2F: a family of transcription factors involved in proliferation control
Black, A. R., & Azizkhan‐Clifford, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00305-4 · Cited by 121
DNA Methylation and Histone Modification in Hypertension
Stoll, S., Wang, C., & Qiu, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041174 · Cited by 122
Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer’s Disease
Maity, S., Farrell, K., Navabpour, S., Narayanan, S. N., & Jarome, T. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212280 · Cited by 130
Chan, J. C., & Maze, I. S. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.05.009 · Cited by 126
Ho, Y., Elefant, F., Cooke, N. E., & Liebhaber, S. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00447-1 · Cited by 119
Ito, M., Park, Y., Weck, J., Mayo, K. E., & Jameson, J. L. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.1.0410 · Cited by 118
He, S., Bauman, D. R., Davis, J. S., Loyola, A., Nishioka, K., Gronlund, J. L., Reinberg, D., Meng, F., Kelleher, N. L., & McCafferty, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2035256100 · Cited by 116
Albaugh, B. N., Arnold, K. M., & Denu, J. M. (2010) · ChemBioChem · doi:10.1002/cbic.201000438 · Cited by 120
Mariadason, J. M., Velcich, A., Wilson, A. J., Augenlicht, L. H., & Gibson, P. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.22472 · Cited by 118
Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development
Whisenhunt, T. R., Yang, X., Bowe, D. B., Paterson, A. J., Tine, B. A. V., & Kudlow, J. E. (2006) · Glycobiology · doi:10.1093/glycob/cwj096 · Cited by 132
Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing’s sarcoma
Dai, X., Ma, W., He, X., & Jha, R. K. (2011) · Medical Science Monitor · doi:10.12659/msm.881893 · Cited by 117
Adenovirus and cell cycle control
Ben-Israel, H. (2002) · Frontiers in bioscience · doi:10.2741/ben · Cited by 117
Gaggioli, C., Buscà, R., Abbe, P., Ortonne, J. P., & Ballotti, R. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00057.x · Cited by 117
Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor
Wang, H. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.12.2517 · Cited by 117
Tagami, T., Park, Y., & Jameson, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22345 · Cited by 121
A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFbPreprint
Zhang, F., Barborič, M., Blackwell, T. K., & Peterlin, B. M. (2003) · Genes & Development · doi:10.1101/gad.1068203 · Cited by 117
Pollutants inducing epigenetic changes and diseases
Sharavanan, V. J., Sivaramakrishnan, M., Sivarajasekar, N., Senthilrani, N., Kothandan, R., Dhakal, N., Sivamani, S., Show, P. L., Awual, M. R., & Naushad, M. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-019-00944-3 · Cited by 120
Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3–Rpd3 histone deacetylase
Arévalo-Rodrı́guez, M., Cardenas, M. E., Wu, X., Hanes, S. D., & Heitman, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.14.3739 · Cited by 116
Chen, Y., Hims, M. M., Shetty, R. S., Mull, J., Liu, L., Leyne, M., & Slaugenhaupt, S. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01313-08 · Cited by 120
Cotter, M. A., & Robertson, E. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5722-5735.2000 · Cited by 116
Yang, H., Lan, P., Hou, Z., Guan, Y., Zhang, J., Xu, W., Tian, Z., & Zhang, C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.547 · Cited by 115
Targeting Histone Deacetylases as a Multifaceted Approach to Treat the Diverse Outcomes of Stroke
Langley, B. C., Brochier, C., & Rivieccio, M. A. (2009) · Stroke · doi:10.1161/strokeaha.108.540229 · Cited by 115
Reading and Function of a Histone Code Involved in Targeting Corepressor Complexes for Repression
Yoon, H., Choi, Y., Cole, P. A., & Wong, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.324-335.2005 · Cited by 115
Yang, W., Yao, Y., & Seto, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4814 · Cited by 112
The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation
Gilbert, J., Gore, S. D., Herman, J. G., & Carducci, M. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0297 · Cited by 114
Nuclear Localization of CBF1 Is Regulated by Interactions with the SMRT Corepressor Complex
Zhou, S. S., & Hayward, S. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6222-6232.2001 · Cited by 114
Protein kinase CK2 is a key activator of histone deacetylase in hypoxia‐associated tumors
Pluemsampant, S., Safronova, O. S., Nakahama, K., & Morita, I. (2007) · International Journal of Cancer · doi:10.1002/ijc.23094 · Cited by 114
Polybromo-1: The chromatin targeting subunit of the PBAF complex
Thompson, M. J. (2008) · Biochimie · doi:10.1016/j.biochi.2008.10.019 · Cited by 113
Epigenomes as therapeutic targets
Hamm, C. A., & Costa, F. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.003 · Cited by 114
Zhang, F., Wang, L., Ko, E. E., Shao, K., & Qiao, H. (2018) · The Plant Cell · doi:10.1105/tpc.17.00671 · Cited by 113
Solari, F., Bateman, A. G., & Ahringer, J. (1999) · Development · doi:10.1242/dev.126.11.2483 · Cited by 112
The Rpd3 histone deacetylase is required for segmentation of the Drosophila embryo
Mannervik, M., & Levine, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6797 · Cited by 113
Nuclear Glycogenolysis Modulates Histone Acetylation in Human Non-Small Cell Lung Cancers
Sun, R. C., Dukhande, V. V., Zhou, Z., Young, L. E. A., Emanuelle, S., Brainson, C. F., & Gentry, M. S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.014 · Cited by 112
Park, P., Lim, R. W., & Shukla, S. D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2005 · Cited by 112
Zhang, Y., & Dufau, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204417200 · Cited by 112
Rombouts, K. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5577 · Cited by 111
ZIC1 is downregulated through promoter hypermethylation in gastric cancer
Wang, L. J., Jin, H., Wang, X., Lam, E. K. Y., Zhang, J., Liu, X., Chan, F. K. L., Min, J., & Sung, J. J. �. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.180 · Cited by 111
Xiong, H., Du, W., Zhang, Y., Hong, J., Su, W., Tang, J. T., Wang, Y., Lu, R., & Fang, J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20777 · Cited by 111
Site-specific Loss of Acetylation upon Phosphorylation of Histone H3
Edmondson, D. G., Davie, J. K., Zhou, J., Mirnikjoo, B., Tatchell, K., & Dent, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200651200 · Cited by 111
Fan, Q., An, L., & Cui, L. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.264-276.2004 · Cited by 110
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
Martínez-Iglesias, O. A., Ruiz-Llorente, L., Sánchez‐Martínez, R., García, L. D. D., Zambrano, A., & Aranda, A. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0221-x · Cited by 112
Yin, Z., Chen, C., Yang, J., Feng, W., Liu, X., Zuo, R., Wang, J., Yang, L., Zhong, K., Gao, C., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1580104 · Cited by 110
Sensing of Ionizing Radiation-induced DNA Damage by ATM through Interaction with Histone Deacetylase
Kim, G. D., Choi, Y. H., Dimtchev, A., Jeong, S. J., Dritschilo, A., & Jung, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31127 · Cited by 109
Cancer epigenetics: above and beyond
Brait, M., & Sidransky, D. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.562671 · Cited by 115
Small molecules for reprogramming and transdifferentiation
Qin, H., Zhao, A., & Fu, X. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2586-x · Cited by 109
Nakamura, T., Kukita, T., Shobuike, T., Nagata, K., Wu, Z., Ogawa, K., Hotokebuchi, T., Kohashi, O., & Kukita, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5809 · Cited by 109
Acetyltransferases (HATs) as Targets for Neurological Therapeutics
Schneider‐Anthony, A., Chatterjee, S., Bousiges, O., Selvi, B. R., Swaminathan, A., Cassel, R., Blanc, F., Kundu, T. K., & Boutillier, A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0204-7 · Cited by 120
White‐Cooper, H., Leroy, D., MacQueen, A. J., & Fuller, M. T. (2000) · Development · doi:10.1242/dev.127.24.5463 · Cited by 109
Gore, S. D., & Carducci, M. A. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.12.2923 · Cited by 109
Eμ-BRD2 transgenic mice develop B-cell lymphoma and leukemia
Greenwald, R. J., Tumang, J. R., Sinha, A., Currier, N. V., Cardiff, R. D., Rothstein, T. L., Faller, D. V., & Denis, G. V. (2003) · Blood · doi:10.1182/blood-2003-06-2116 · Cited by 112
Chromatin Remodeling and Cancer
Davis, P. K., & Brachmann, R. K. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.189 · Cited by 108
Dorjsuren, D. G., Lin, Y., Wei, W., Yamashita, T., Nomura, T., Hayashi, N., & Murakami, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7546 · Cited by 107
Interaction of Bovine Papillomavirus E2 Protein with Brd4 Stabilizes Its Association with Chromatin
McPhillips, M. G., Ozato, K., & McBride, A. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8920-8932.2005 · Cited by 107
Functional analysis of a RPD3 histone deacetylase homologue in Arabidopsis thaliana
Wu, K., Malik, K., Tian, L., Brown, D. C., & Miki, B. L. A. (2000) · Plant Molecular Biology · doi:10.1023/a:1006498413543 · Cited by 107
Kim, Y. J., Wang, R., Gao, L., Li, D., Xu, C., Mang, H., Jeon, J., Chen, X., Zhong, X., Kwak, J. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618618114 · Cited by 106
Abdizadeh, T., Kalani, M. R., Abnous, K., Tayarani‐Najaran, Z., Khashyarmanesh, B. Z., Abdizadeh, R., Ghodsi, R., & Hadizadeh, F. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.024 · Cited by 106
Arévalo-Rodrı́guez, M. (2004) · Frontiers in bioscience · doi:10.2741/1405 · Cited by 105
Hiroi, M., & Ohmori, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204544200 · Cited by 106
Epialleles — a source of random variation in times of stress
Finnegan, E. J. (2002) · Current Opinion in Plant Biology · doi:10.1016/s1369-5266(02)00233-9 · Cited by 109
Kim, D., & Lassar, A. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8704-8717.2003 · Cited by 106
Epigenetic Regulation of Gelsolin Expression in Human Breast Cancer Cells
Mielnicki, L. M., Ying, A., Head, K. L., Asch, H. L., & Asch, B. B. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4461 · Cited by 106
Diet-induced Lethality Due to Deletion of the Hdac3 Gene in Heart and Skeletal Muscle
Sun, Z., Singh, N., Mullican, S. E., Everett, L. J., Li, L., Yuan, L., Liu, X., Epstein, J. A., & Lazar, M. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277707 · Cited by 104
Histone acetylation and the cell-cycle in cancer
Wang, C. (2001) · Frontiers in bioscience · doi:10.2741/1wang1 · Cited by 103
Ying, M., Xu, R., Wu, X., Zhu, H., Zhuang, Y., Han, M., & Xu, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511677200 · Cited by 103
Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma
Kavanaugh, S. M., White, L. A., & Kolesar, J. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090247 · Cited by 102
Ant phylogenomics reveals a natural selection hotspot preceding the origin of complex eusociality
Romiguier, J., Borowiec, M. L., Weyna, A., Helleu, Q., Loire, É., Mendola, C. L., Rabeling, C., Fisher, B. L., Ward, P. S., & Keller, L. (2022) · Current Biology · doi:10.1016/j.cub.2022.05.001 · Cited by 107
Martin, C., Oeser, J. K., Svitek, C., Hunter, S., Hutton, J., & O'Brien, R. M. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290205 · Cited by 102
Sodium butyrate induces P53‐independent, Fas‐mediated apoptosis in MCF‐7 human breast cancer cells
Chopin, V., Toillon, R., Jouy, N., & Bourhis, X. L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704456 · Cited by 103
Zhang, Y., Fatima, N., & Dufau, M. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.7929-7939.2005 · Cited by 104
Yang, C., Chen, Y., Chi, P., Lin, C., & Hsiao, L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.003 · Cited by 103
Cardiac Hypertrophy: Molecular and Cellular Events
Carreño, J. E., Apablaza, F., Ocaranza, M. P., & Jalil, J. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60796-2 · Cited by 101
A non-isotopic assay for histone deacetylase activity
Hoffmann, K., Jung, M., Brosch, G., & Loidl, P. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.9.2057 · Cited by 102
Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors
Sakimura, R., Tanaka, K., Nakatani, F., Matsunobu, T., Li, X., Hanada, M., Okada, T., Nakamura, T., Matsumoto, Y., & Iwamoto, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21069 · Cited by 101
TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3
Wang, L., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204479 · Cited by 101
Bordoli, L. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.589 · Cited by 100
Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway
Hinoi, T., Loda, M. F., & Fearon, E. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307435200 · Cited by 100
Martens, J. H. A., Verlaan, M., Kalkhoven, E., Dorsman, J. C., & ZANTEMA, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2598-2606.2002 · Cited by 102
Brès, V., Tagami, H., Péloponèse, J., Loret, E. P., Jeang, K., Nakatani, Y., Emiliani, S., Benkirane, M., & Kiernan, R. E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf669 · Cited by 100
Epigenetics and rheumatoid arthritis: The role of SENP1 in the regulation of MMP-1 expression
Maciejewska-Rodrigues, H., Karouzakis, E., Strietholt, S., Hemmatazad, H., Neidhart, M., Ospelt, C., Gay, R. E., Michel, B. A., Pap, T., Gay, S., et al. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.010 · Cited by 99
From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics
Bode, J., Götze, S., Heng, H. H., Krawetz, S. A., & Benham, C. J. (2003) · Chromosome Research · doi:10.1023/a:1024918525818 · Cited by 99
Chua, Y. L., Brown, A. P. C., & Gray, J. C. (2001) · The Plant Cell · doi:10.1105/tpc.13.3.599 · Cited by 99
Evidence of Endogenous Mu Opioid Receptor Regulation by Epigenetic Control of the Promoters
Hwang, C. K., Song, K. Y., Kim, C. S., Choi, H. S., Guo, X., Law, P., Wei, L., & Loh, H. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00073-07 · Cited by 97
Control of plant cell differentiation by histone modification and DNA methylation
Ikeuchi, M., Iwase, A., & Sugimoto, K. (2015) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2015.09.004 · Cited by 97
Subramaniam, N., Treuter, E., & Okret, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.18121 · Cited by 99
LaBonte, M. J., Wilson, P. M., Fazzone, W., Groshen, S., Lenz, H.-J., & Ladner, R. D. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-67 · Cited by 99
Tip60 Is a Co-activator Specific for Class I Nuclear Hormone Receptors
Gaughan, L., Brady, M. E., Cook, S., Neal, D. E., & Robson, C. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103710200 · Cited by 98
Targeting histone deacetylases for the treatment of cancer and inflammatory diseases
Huang, L. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20781 · Cited by 98
Scott, M. J., Pan, L. L., Cleland, S. B., Knox, A. L., & Heinrich, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.144 · Cited by 102
Countryman, J. K., Gradoville, L., & Miller, G. (2008) · Journal of Virology · doi:10.1128/jvi.00116-08 · Cited by 99
Sikes, M. L., Meade, A., Tripathi, R., Krangel, M. S., & Oltz, E. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182166699 · Cited by 98
Agata, Y., Katakai, T., Ye, S., Sugai, M., Gonda, H., Honjo, T., Ikuta, K., & Shimizu, A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.873 · Cited by 97
The putative nuclear receptor mediator TIF1α is tightly associated with euchromatin
Remboutsika, E., Lutz, Y., Gansmüller, A., Vonesch, J., Losson, R., & Chambon, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.11.1671 · Cited by 97
Fernández, L. Á., Winkler, M., & Grosschedl, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.196-208.2001 · Cited by 97
The Histone Modification Code in the Pathogenesis of Autoimmune Diseases
Araki, Y., & Mimura, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/2608605 · Cited by 100
Metadata
- Authors
- Struhl, K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Struhl, K.
- ORCID
- Struhl, K.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1998-03-01
- Volume
- 12
- Issue
- 5
- Pages
- 599-606
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2106900373
- Cited by
- 1,815
- References
- 61
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 36 · 2023: 35 · 2022: 34 · 2021: 40 · 2020: 40 · 2019: 45 · 2018: 48 · 2017: 65 · 2016: 51 · 2015: 48 · 2014: 57 · 2013: 49 · 2012: 47
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (GM30186)
- National Institute of General Medical Sciences (GM30186, GM-53720, R01GM053720)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- histone acetylation, histone deacetylase, transcriptional regulation, chromatin structure, histone acetyltransferase, nucleosome conformation, histone lysine acetylation, histone methylation, histone phosphorylation, histone H3, histone H2A
- MeSH terms
- Acetylation, Acetylesterase, Acetyltransferases, Animals, Gene Expression Regulation, Histone Deacetylases, Histones, Models, Biological, Proteins, Transcription Factors, Transcription, Genetic, Saccharomyces cerevisiae Proteins, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review